Coronavir

Novel Coronavirus SARS-CoV-2

Coronavir is an anti-viral drug approved in Russia for the treatment of COVID-19. Little is known of this drug, except for the information released by its developer R-Pharm.[1][2]

By the description provided to the press, coronavir seems to be an inhibitor of SARS-CoV-2 RNA polymerase, similar to other antiviral nucleotide analogues such as remdesivir.[1] The drug appears to be based on favipiravir, a drug developed in Japan.[3]

Coronavir was approved for use in Russia in hospitals in July 2020, and in September 2020 it received approval for prescription sales for outpatient use.[3]

## See also[edit]

* COVID-19 pandemic in Russia

## References[edit]

1. ^ a b "Russian firm gets approval for drug said to block coronavirus replication". July 8, 2020 - via in.reuters.com.
2. ^ "Russia approves R-Pharm's Coronavir for Covid-19 treatment". Pharmaceutical Technology. 9 July 2020. Retrieved 21 July 2020.
3. ^ a b Reuters Staff (2020-09-18). "Russia approves first COVID-19 prescription drug for sale in pharmacies". Reuters (in French). Retrieved 2020-09-20.[dead link]

This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it.

|

* v
* t
* e

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template